entertainment -WSS

entertainment

author：Wikipedia 2025-10-01 10:57:43 - browse：83574

Boxes of Wegovy. -- health coverage from STAT — Bloomberg

A landmark study that found the blockbuster obesity drug Wegovy reduces the chance of heart problems adds urgency to a basic question in medicine: what exactly is the relationship between weight and health?

On its face, the result that Wegovy cut the risk of major cardiovascular complications by 20% lends credence to arguments by drugmakers, including Wegovy manufacturer Novo Nordisk, that obesity is a disease and weight loss makes people healthier.

But researchers and doctors cautioned that the results don’t prove obesity treatments improve heart health solely by helping people lose weight. It’s likely that weight loss is one cause, they said, but there could be other key mechanisms at play independent from Wegovy’s effect on body weight.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： What Henrietta Lacks's story taught me about my role as a doctor

WSS

Burning questions about Delta and the next phase of the Covid pandemic

The pink breast cancer awareness ribbon needs a redesign

First Opinion Podcast: How to protect health care in times of war

Emergency medicine has repudiated 'excited delirium.' Now what?

How a key Senate committee is planning to regulate PBMs

Testing for cancer recurrence creates a new limbo for patients

hotspot

entertainment

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

FDA approves first blood sugar monitor without finger pricks

Walensky prepares to leave CDC — and Congress — behind

Burning questions about Delta and the next phase of the Covid pandemic

In age of alternative facts, a scholarly course on calling out crap

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

In age of alternative facts, a scholarly course on calling out crap

Why Sanofi got shellacked over its spinoff

Alkermes shareholders re

Meta's Zuckerberg and Chan on track to put $50 billion into science

focus

Diversifying clinical trials isn't enough to close racial gaps: study

Medtronic CEO on promising devices for diabetes, hypertension

Doctors have an ethical obligation to be advocates

Medtronic CEO on promising devices for diabetes, hypertension

Medtronic CEO on promising devices for diabetes, hypertension

The pink breast cancer awareness ribbon needs a redesign

hotspot

focus

hotspot

leisure time